Get the Stockscreener App
5.21
1.37%
0.08
Cellectar Biosciences Inc stock is traded at $5.21, with a volume of 32,246.
It is up +1.37% in the last 24 hours and up +19.82% over the past month.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
See More
Previous Close:
$5.13
Open:
$5.11
24h Volume:
32,246
Relative Volume:
0.09
Market Cap:
$16.50M
Revenue:
-
Net Income/Loss:
$-37.75M
P/E Ratio:
-1.6031
EPS:
-3.25
Net Cash Flow:
$-30.91M
1W Performance:
+4.01%
1M Performance:
+19.82%
6M Performance:
+1,444%
1Y Performance:
+146.46%
1-Day Range:
$5.11
$5.345
1-Week Range:
$4.82
$5.345
52-Week Range:
$0.224
$10.19
Cellectar Biosciences Inc Stock (CLRB) Company Profile
Name
Cellectar Biosciences Inc
Sector
Industry
Phone
(608) 441-8120
Address
100 CAMPUS DRIVE, FLORHAM PARK, NJ
Compare CLRB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLRB
Cellectar Biosciences Inc
|
5.17 | 16.38M | 0 | -37.75M | -30.91M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.11 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
581.90 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
455.52 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
737.38 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.60 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-24 | Resumed | Ladenburg Thalmann | Buy |
| Jul-01-20 | Initiated | Oppenheimer | Outperform |
| Jan-21-20 | Resumed | ROTH Capital | Buy |
| Sep-13-19 | Initiated | ROTH Capital | Buy |
| Dec-21-16 | Initiated | Ladenburg Thalmann | Buy |
Cellectar Biosciences Inc Stock (CLRB) Latest News
Comparing Cellectar Biosciences Inc. in custom built stock radarsPortfolio Risk Summary & Expert Curated Trade Setup Alerts - newser.com
Order flow analysis tools used on Cellectar Biosciences Inc.Inflation Watch & Fast Exit and Entry Strategy Plans - newser.com
Forecast Cut: How does Cellectar Biosciences Inc compare to its peersSell Signal & Daily Profit Focused Stock Screening - خودرو بانک
VIX Spike: Is Cellectar Biosciences Inc currently under institutional pressureTrade Risk Report & Community Trade Idea Sharing Platform - خودرو بانک
Cellectar Biosciences Inc. stock trendline breakdown2025 Market Outlook & Long Hold Capital Preservation Tips - newser.com
Value Recap: Is Cellectar Biosciences Inc a top pick in the sectorEarnings Miss & Reliable Intraday Trade Plans - خودرو بانک
Earnings Risk: Is Cellectar Biosciences Inc. a strong candidate for buy and holdDay Trade & Stepwise Trade Execution Plans - خودرو بانک
Aug PreEarnings: Is Cellectar Biosciences Inc a potential multi baggerJuly 2025 Breakouts & Risk Managed Investment Strategies - خودرو بانک
Chart Watch: What drives Cellectar Biosciences Incs stock priceTrade Exit Summary & Low Risk High Reward Trade Ideas - خودرو بانک
Can trapped investors hope for a rebound in Cellectar Biosciences Inc.2025 Market Trends & Fast Entry Momentum Trade Alerts - newser.com
Aug Update: Can Critical Metals Corp. scale operations efficiently2025 Risk Factors & Stock Portfolio Risk Management - خودرو بانک
Decliners Report: What is Cellectar Biosciences Inc. s revenue forecastPrice Action & AI Forecast for Swing Trade Picks - خودرو بانک
Earnings Recap: Can Cellectar Biosciences Inc disrupt its industryJuly 2025 Gainers & AI Driven Stock Movement Reports - خودرو بانک
Aug Gainers: What is Cellectar Biosciences Inc. s debt to equity ratioPortfolio Value Summary & Advanced Technical Signal Analysis - خودرو بانک
Can Cellectar Biosciences Inc. recover in the next quarterJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com
Analysis Recap: What is Cellectar Biosciences Inc. s revenue forecast2025 Key Highlights & Weekly Breakout Watchlists - خودرو بانک
Travel Stocks: Will Cellectar Biosciences Inc stock benefit from M AShort Setup & AI Enhanced Trading Alerts - خودرو بانک
Activity Recap: Will Cellectar Biosciences Inc benefit from rising consumer demandJuly 2025 Decliners & Target Return Focused Stock Picks - خودرو بانک
Bull Run: How cyclical is Cellectar Biosciences Incs revenue streamJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Insider Trends: Whats the fair value of Cellectar Biosciences Inc stock2025 Technical Patterns & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Meme Stocks: Can Cellectar Biosciences Inc weather a recessionTrade Entry Summary & Growth Oriented Trade Recommendations - خودرو بانک
Combining machine learning predictions for Cellectar Biosciences Inc.2025 Price Momentum & Community Verified Trade Alerts - newser.com
Bull Run: What is Cellectar Biosciences Inc. s revenue forecast2025 Earnings Impact & Real-Time Volume Analysis - خودرو بانک
What to do if you’re stuck in Cellectar Biosciences Inc.Weekly Stock Summary & Expert Verified Movement Alerts - newser.com
Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225 - Investing News Network
Cellectar Biosciences and ITM enter supply agreement for GMP-grade actinium-225 - MarketScreener
Cellectar Biosciences and ITM Isotope Technologies Munich SE Announce Supply Agreement for Actinium-225 to Advance Cancer Treatment Development - Quiver Quantitative
Critical Isotope Supply Deal: Cellectar Secures Ac-225 from ITM for Novel Pancreatic Cancer Treatment - Stock Titan
How to read the order book for Cellectar Biosciences Inc.Chart Signals & AI Optimized Trading Strategy Guides - Newser
How to use Fibonacci retracement on Cellectar Biosciences Inc.2025 Year in Review & Long-Term Capital Growth Ideas - Newser
Cellectar Biosciences to Participate at Oppenheimer 3rd - GlobeNewswire
Cellectar Biosciences Progresses in EMA and FDA Pathways for Iopofosine I 131 and Advances CLR 125 for Triple-Negative Breast Cancer - Quiver Quantitative
Major Breakthrough: Cellectar's Cancer Drug Iopofosine I 131 Approaches Dual EU-US Regulatory Milestones - Stock Titan
Cellectar Biosciences Inc. At Decision Level — Rebound or Resistance2025 Performance Recap & Intraday High Probability Alerts - beatles.ru
Cellectar Biosciences Inc. Shows Support at Fibonacci Level2025 Sector Review & Long-Term Capital Growth Strategies - beatles.ru
Can Cellectar Biosciences Inc. expand its profit marginsJuly 2025 Sector Moves & Free Verified High Yield Trade Plans - beatles.ru
Price Channel Expanding on Cellectar Biosciences Inc.’s ChartStop Loss & Capital Efficient Trading Techniques - beatles.ru
Traders Consider Averaging Down in Cellectar Biosciences Inc.Quarterly Portfolio Report & Accurate Intraday Trade Tips - beatles.ru
Is it time to cut losses on Cellectar Biosciences Inc.2025 Top Gainers & Free Weekly Watchlist of Top Performers - Newser
Building trade automation scripts for Cellectar Biosciences Inc.July 2025 EndofMonth & High Conviction Buy Zone Picks - Newser
Regression analysis insights on Cellectar Biosciences Inc. performanceCPI Data & AI Based Buy/Sell Signal Reports - Newser
Market Leaders: What drives Cellectar Biosciences Inc.’s stock price2025 Pullback Review & Accurate Buy Signal Alerts - خودرو بانک
Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September - GlobeNewswire
What is Cellectar Biosciences Inc. s debt to equity ratioTrade Entry Report & Long-Term Growth Stock Strategies - خودرو بانک
Using fundamentals and technicals on Cellectar Biosciences Inc.Exit Point & Verified Short-Term Trading Plans - Newser
Chart overlay techniques for tracking Cellectar Biosciences Inc.July 2025 Volume & Real-Time Stock Price Movement Reports - Newser
Statistical indicators supporting Cellectar Biosciences Inc.’s strength2025 Trade Ideas & Weekly Top Performers Watchlists - Newser
Should you hold or exit Cellectar Biosciences Inc. nowJuly 2025 Outlook & Daily Growth Stock Investment Tips - Newser
Does Cellectar Biosciences Inc. show high probability of reboundJuly 2025 Levels & Precise Buy Zone Identification - Newser
Cellectar Biosciences, Inc. Announces Participation in Key Cancer Research Conferences and Panel Discussions This September - Quiver Quantitative
Cellectar Biosciences to Present at Multiple Medical Meetings and Industry Conferences in September. - AInvest
Cellectar Biosciences Inc Stock (CLRB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cellectar Biosciences Inc Stock (CLRB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Longcor Jarrod | Chief Operating Officer |
Jul 02 '25 |
Buy |
4.99 |
10,000 |
49,900 |
12,768 |
| Kolean Chad J | Chief Financial Officer |
Jul 02 '25 |
Buy |
4.99 |
5,000 |
24,950 |
6,418 |
| Longcor Jarrod | Chief Operating Officer |
Jan 10 '25 |
Buy |
0.28 |
30,000 |
8,400 |
83,141 |
0.72%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):